Ciguatoxins (CTXs) are lipophilic neurotoxins produced by Gambierdiscus spp. that can bioaccumulate through food webs until reaching humans, causing ciguatera poisoning (CP). This study aims to investigate the presence and distribution of CTXs in different fish and shark species from La Réunion (Indian Ocean), with a focus on flesh and liver analysis. Twenty-four CBA-positive fish specimens, randomly sampled between 2022 and 2025, belonging to ten species, were analysed in both liver and flesh. CTX-like toxicity was detected in 23 of 24 liver samples (0.0229–0.3099 μg CTX1B equivalents kg⁻¹) and in 20 of 24 flesh samples (0.0037–0.0822 μg CTX1B equivalents kg⁻¹). All positive livers exceeded the FDA guidance level of 0.01 μg CTX1B equivalents kg⁻¹, whereas only 62.5% of flesh samples surpassed this threshold. UPLC-MS/MS confirmed CTX1B in nine specimens at concentrations ranging from 0.006 to 0.018 μg kg⁻¹, predominantly in liver samples, while 52-epi-54-deoxyCTX1B was additionally identified in two liver samples. Furthermore, six CBA-positive sharks, comprising one Galeocerdo cuvier and five Carcharhinus leucas, were analysed, reporting in all cases higher CTX-like toxicities in liver, reaching values of 5.23 μg CTX1B equivalents kg⁻¹. In addition, I-CTX analogues were detected in the liver of one C. leucas, supporting the occurrence of CTXs in sharks and highlighting their potential role as toxin reservoirs. Matrix effects after SPE were evaluated by UPLC-MS/MS. Unlike teleost fish, which showed negligible effects, shark flesh and liver exhibited significant matrix effects, highlighting their greater analytical complexity and the need for species-specific validation to ensure accurate CTX quantification. These findings reinforce the liver as a key target tissue for CTX study and monitoring. It also gives insights into the occurrence of CTXs in apex predators such as sharks and underlines the importance of adapting analytical methodologies according to matrix composition.